THE EARLY BENEFIT ASSESSMENT OF DRUGS THAT ARE LAUNCHED BEFORE 2011

被引：0
|
作者：
Weber, B. [1 ]
机构：
[1] Pfizer, Berlin, Germany
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.694
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A315 / A316
页数：2
相关论文
共 50 条
  • [21] RISK-BENEFIT ASSESSMENT OF TOCOLYTIC DRUGS
    WISCHNIK, A
    DRUG SAFETY, 1991, 6 (05) : 371 - 380
  • [22] PRIORITIES IN THE BENEFIT RISK ASSESSMENT OF NEW DRUGS
    VENNING, GR
    ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1984, 3 (02): : 113 - 121
  • [23] Health-related quality of life and patient preferences in early benefit assessment of cancer drugs
    Schubert, A.
    Zentner, A.
    Tebinka-Olbrich, A.
    Haas, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 294 - 294
  • [24] The Involvement of scientific Societies in the early Benefit Assessment of Drugs: The simulated Participation or valuable additional Information?
    Lange, Stefan
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2018, 130 : 58 - 59
  • [25] Assessing the added benefit of new ophthalmic drugs. Which additional insights can be extracted from the early benefit assessment?
    Appelrath, M.
    Glaeske, G.
    OPHTHALMOLOGE, 2017, 114 (12): : 1135 - 1148
  • [26] Indirect Comparisons in Early Benefit Assessment
    Moeser, G.
    Ecker, C.
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2013, 18 (05): : 235 - 243
  • [27] Benefit of feeding assessment before pediatric airway reconstruction
    Willging, JP
    LARYNGOSCOPE, 2000, 110 (05): : 825 - 834
  • [28] Issues of Additional Benefit Quantification within the Early Benefit Assessment
    Witte, J.
    Greiner, W.
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2013, 18 (05): : 226 - 234
  • [29] Re: "Early benefit assessment of new drugs in Germany Results from 2011 to 2012" [Health Policy 116 (2-3) (2014) 147-153]
    Orben, Tina
    Rasch, Andrej
    Dintsios, Charalabos-Markos
    HEALTH POLICY, 2014, 118 (02) : 271 - 271
  • [30] THE BENEFIT OF EARLY TREATMENT WITH IMMUNOSUPPRESSIVE DRUGS IN LUPUS NEPHRITIS
    ESDAILE, JM
    JOSEPH, L
    MACKENZIE, T
    KASHGARIAN, M
    HAYSLETT, JP
    JOURNAL OF RHEUMATOLOGY, 1995, 22 (06) : 1211 - 1211
12345